Deakin University
Browse
ward-evolutionofclass-2007.pdf (537.15 kB)

Evolution of class I cytokine receptors

Download (537.15 kB)
journal contribution
posted on 2007-01-01, 00:00 authored by Clifford LiongueClifford Liongue, Alister WardAlister Ward
Background
The Class I cytokine receptors have a wide range of actions, including a major role in the development and function of immune and blood cells. However, the evolution of the genes encoding them remains poorly understood. To address this we have used bioinformatics to analyze the Class I receptor repertoire in sea squirt (Ciona intestinalis) and zebrafish (Danio rerio).
Results
Only two Class I receptors were identified in sea squirt, one with homology to the archetypal GP130 receptor, and the other with high conservation with the divergent orphan receptor CLF-3. In contrast, 36 Class I cytokine receptors were present in zebrafish, including representative members for each of the five structural groups found in mammals. This allowed the identification of 27 core receptors belonging to the last common ancestor of teleosts and mammals.
Conclusion
This study suggests that the majority of diversification of this receptor family occurred after the divergence of urochordates and vertebrates approximately 794 million years ago (MYA), but before the divergence of ray-finned from lobe-finned fishes around 476 MYA. Since then, only relatively limited lineage-specific diversification within the different Class I receptor structural groups has occurred.

History

Journal

BMC evolutionary biology

Volume

7

Pagination

1 - 15

Location

London, England

Open access

  • Yes

ISSN

1471-2148

Language

eng

Notes

This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Publication classification

C1 Refereed article in a scholarly journal

Copyright notice

2007, Liongue and Ward; licensee BioMed Central Ltd.